Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03402269 · ClinicalTrials.gov registry record

Treatment of Pediatric Mid-shaft Clavicle Fractures: A Prospective, Observational Study

A clinical trial, sponsored by Prisma Health-Upstate.

Completed
Registry status
30
Enrollment target

NCT03402269: Completed study, sponsored by Prisma Health-Upstate.

NCT03402269 is a clinical trial that has completed, run by Prisma Health-Upstate. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03402269 has completed, sponsored by Prisma Health-Upstate.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

Clavicle fractures in children are common. Typical treatment includes nonoperative treatment with a sling. Operative treatment is usually limited to open, unstable, fractures with either epidermal risks or neurovascular compromise. Orthopaedic literature has many studies that report the need for additional research for this prevalent fracture. This is an observational study evaluating the functional and patient reported outcomes of displaced clavicle fractures in adolescents. The results from this study will help the orthopedist understand the expected outcomes for a given pediatric patient with a clavicle fracture.

Primary Outcome

Range of motion measured by goniometer

Interventions

  • OTHER Clavicle fracture injury- observation

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-01-10
Est. Completion 2022-12-31
Prisma Health-Upstate

67 total trials

What the finished NCT03402269 record still lists

NCT03402269 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Clavicle fracture injury- observation is the first listed.

NCT03402269 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03402269 about?

NCT03402269 is a clinical study titled "Treatment of Pediatric Mid-shaft Clavicle Fractures: A Prospective, Observational Study". Clavicle fractures in children are common. Typical treatment includes nonoperative treatment with a sling. Operative treatment is usually limited to open, unstable, fractures with either epidermal risks or neurovascular compromise. Orthopaedic literature has many studies that report the need for add...

What is the current status of trial NCT03402269?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2018-01-10. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT03402269?

The interventions under investigation include: Clavicle fracture injury- observation (OTHER).

Who is sponsoring clinical trial NCT03402269?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03402269, the US trial registry maintained by the National Library of Medicine. NCT03402269 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.